Literature DB >> 10556148

Microsatellite DNA instability and loss of heterozygosity in pulmonary sarcoidosis.

D A Vassilakis1, G Sourvinos, M Markatos, K Psathakis, D A Spandidos, N M Siafakas, D Bouros.   

Abstract

In the present study we investigated the incidence of microsatellite instability (MI) and loss of heterozygosity (LOH) in sarcoidosis, a multisystem disease of unknown origin. We examined sputum cytological specimens from 30 patients with sarcoidosis and 30 healthy, matched subjects, using 10 highly polymorphic microsatellite markers located at several chromosomal arms. The electrophoretic pattern of each specimen was compared with the corresponding pattern of peripheral blood and any difference in the mobility of the microsatellite alleles was interpreted as MI-positive. LOH was scored as decrease in intensity of one allele relative to the other as determined from comparison of sputum and normal (blood) DNA. We found that 14 (47%) sarcoidosis patients showed genetic alterations, either MI or LOH. Six (20%) patients exhibited MI and nine (30%) exhibited LOH in at least one microsatellite marker. One of the patients exhibited MI in two microsatellite markers and three (10%) showed LOH in more than one marker. One patient showed complete deletion of the chromosomal arm 17q11.2-q21. None of the healthy subjects exhibited any genetic alteration in the studied markers. No correlation was found between the genetic alterations detected and age, disease duration, blood gases, or spirometric parameters of the patients. Our findings suggest that MI is a detectable phenomenon in sarcoidosis and seems not to be related with the severity of the disease. The detection of LOH indicates the presence of putative tumor suppressor genes at loci examined, which may play an important role in the etiopathogenesis of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556148     DOI: 10.1164/ajrccm.160.5.9903146

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

Review 1.  A case of pulmonary sarcoidosis preceding polycythemia vera with literature review.

Authors:  Daniela Tirotta; Vittorio Durante
Journal:  Rheumatol Int       Date:  2010-03-13       Impact factor: 2.631

2.  Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancer.

Authors:  Li Zhang; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Jiro Kato; Mary Haughey; Joseph R Fontana; Vincent C Manganiello; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

3.  Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.

Authors:  Imre Noth; Yingze Zhang; Shwu-Fan Ma; Dan Nicolae; Naftali Kaminski; Joe G N Garcia; Carlos Flores; Mathew Barber; Yong Huang; Steven M Broderick; Michael S Wade; Pirro Hysi; Joseph Scuirba; Thomas J Richards; Brenda M Juan-Guardela; Rekha Vij; MeiLan K Han; Fernando J Martinez; Karl Kossen; Scott D Seiwert; Jason D Christie
Journal:  Lancet Respir Med       Date:  2013-04-17       Impact factor: 30.700

4.  Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension.

Authors:  S M Majka; M Skokan; L Wheeler; J Harral; S Gladson; E Burnham; J E Loyd; K R Stenmark; M Varella-Garcia; J West
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-17       Impact factor: 5.464

5.  Sarcoidosis in a 65-year-old woman presenting with a lung mass and pericardial effusion: a case report.

Authors:  George A Margaritopoulos; Athanasia Proklou; Eleni Lagoudaki; Argiro Voloudaki; Nikos M Siafakas; Katerina M Antoniou
Journal:  J Med Case Rep       Date:  2012-08-31

6.  Chronic Inflammation as the Underlying Mechanism of the Development of Lung Diseases in Psoriasis: A Systematic Review.

Authors:  Mateusz Mleczko; Agnieszka Gerkowicz; Dorota Krasowska
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.